Affiliation: Novartis Institutes for BioMedical Research
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesJohn Donnelly
Novartis Vaccines and Diagnostics, 53100 Siena, Italy
Proc Natl Acad Sci U S A 107:19490-5. 2010..This assay allows typing of large panels of strains and prediction of coverage of protein-based meningococcal vaccines. Similar assays may be used for protein-based vaccines against other bacteria...
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcusMarzia M Giuliani
Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena 53100, Italy
Vaccine 28:5023-30. 2010....
- Factor H-binding protein, a unique meningococcal vaccine antigenMariagrazia Pizza
Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy
Vaccine 26:I46-8. 2008..fHbp is important for survival in human blood, human sera, and in presence of antimicrobial peptides, independently of its expression level. All these properties make fHbp a unique vaccine antigen...